To compose our ranking tables, Intellectual Asset Management (IAM) magazine has undertaken an extensive research process. Over four months, we conducted telephone interviews and exchanged emails with attorneys-at-law, patent attorneys and users of legal services involved in life sciences patent litigation. We asked all of them to provide us with their detailed insights into which individuals stood out for their expertise in life sciences patent litigation in the jurisdictions covered in this publication. The direct quotes used in the IAM Life Sciences 250 editorial are also drawn from these sources and these exchanges.

Individuals qualify for a listing in the IAM Life Sciences 250 when they receive sufficient positive feedback from peers and clients with knowledge of their practice and the market within which they operate. Nominations are accepted solely from sources who are not with the nominee’s firm. Even then, this does not guarantee inclusion. Only those individuals who further research shows to have exceptional skill sets and profound insights into life sciences patent litigation feature in the IAM Life Sciences 250.

Numerical rankings are determined on the basis of this feedback. The higher the volume of spontaneous recognition that individuals receive, the greater their visibility in the marketplace; the richer in praise the feedback and the more noteworthy their work, the loftier their standing in the market. All these considerations contribute to the decision-making process concerning individuals’ positions on the ranking tables.

Alastair Mitchell
Head of Research
IAM Life Sciences 250